Anesthesia & Pain Management Sponsored by Pacira Pharmaceuticals
Opioid analgesic Opana ER pulled from U.S. market
July 6, 2017 -- Endo Pharmaceuticals has announced it will voluntarily remove its opioid analgesic Opana ER from the U.S. market because of a risk for abuse.  Discuss
Top 5 news stories from spring 2017
June 28, 2017 -- DrBicuspid.com takes a look back at the most-read news and clinical articles from spring 2017, as measured by page views. The most popular article was our coverage of the ADA creating a new licensing exam, followed by our list of the 10 largest dental service/support organizations in the U.S.  Discuss
Top 5 columns from spring 2017
June 28, 2017 -- DrBicuspid.com takes a look back at some of the most-read columns and practice management articles from spring, as measured by page views. These columns focus on a wide variety of topics, from legal cases to regional fee differences to popular columns by periodontist Alvin Danenberg, DDS.  Discuss
Hot Topic
Second Opinion: Outpatient detoxification for opioid-addicted patients

While steps are needed to reduce the number of prescribed opioids in the U.S., what about those patients who may already be addicted and at risk? In this Second Opinion, Vikram Tarugu, MD, details a detoxification program that may be appropriate for your patients and your community. Read more.

Conferences
Parenteral Moderate Sedation Training for Dentists
July 12-28
Los Angeles, California United States
ACLS Training for Dentists & Staff
July 19
Los Angeles, California United States
Sedation Permit Renewal/Refresher for Dentistry
July 20
Los Angeles, California United States
Parenteral Moderate Sedation Training for Dentists
August 9-25
Charlotte, North Carolina United States
ACLS Training for Dentists & Staff
August 16
Charlotte, North Carolina United States